Citations

Clear

14 citation(s) found for "Simadibrata, Daniel M".

Types of Self-Expandable Metal Stents for Palliative Drainage of Unresectable Extrahepatic Malignant Biliary Obstruction: A Network Meta-Analysis of Randomized Controlled Trials
Simadibrata, Daniel M., Aggarwal, Manik , Vanella, Giuseppe , Chandrasekhara, Vinay , Guralwar, Chinmay , Vanella, Giuseppe , Chandrasekhara, Vinay , Hassett, Leslie C.

Mayo Clinic

Endoscopy | August 29, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2948-9408 | PMID 42667933 Get It

Background: The optimal self-expandable metallic stent (SEMS) choice for endoscopic drainage of unresectable extrahepatic malignant biliary obstruction (MBO) with endoscopic retrograde cholangiopancreatography (ERCP) remains unclear due to limited randomized controlled trial (RCT) evidence. Prior meta-analyses have relied on observational data, introducing heterogeneity and bias. To overcome these limitations, an RCT-only network meta-analysis (NMA) was performed to evaluate the efficacy and safety of SEMS types. Methods: A literature search was conducted to identify RCTs assessing fully covered SEMS (FCSEMS), partially covered SEMS (PCSEMS), and/or uncovered SEMS (UCSEMS) for ERCP drainage of unresectable extrahepatic MBO. Study outcomes included recurrent biliary obstruction (RBO), specific causes of RBO, overall survival (OS), and adverse events (AEs). A frequentist NMA was performed to estimate hazard ratios (HRs) and incidence rate ratios (IRRs) with their 95% confidence intervals and overall P-scores. Results: Ten RCTs (1,659 patients) were included. There were no significant differences in time to RBO, incidence of any RBO, or OS between stent types. UCSEMS had the lowest rates of stent migration, tumor overgrowth, and sludge occlusion, whereas FCSEMS most effectively prevented tumor ingrowth. AE rates were similar across groups; however, only FCSEMS, but not PCSEMS, had significantly higher rates of acute cholecystitis than UCSEMS in patients with an intact gallbladder. Conclusion: There were no differences in RBO, OS, or AE excluding acute cholecystitis between each SEMS type, although each type has its advantages and disadvantages. FCSEMS was associated with a higher risk of acute cholecystitis, emphasizing careful patient selection, particularly regarding gallbladder status.
P412 Worldwide prevalence of appendectomy and its association with disorders of gut-brain interaction
Simadibrata, Daniel M, Lamichhane, Ramesh , Al-Fakhouri, Zaid , Alomari, Laith, Cheng, Kueh Yee , Palsson, Olafur S, Sperber, Ami D, Bangdiwala, Shrikant I, Butt, Mohsin F. , Simadibrata, Daniel Martin , Alomari, Laith , Palsson, Olafur S. , Sperber, Ami D , Bangdiwala, Shrikant I. , Lee, Yeong Yeh

Mayo Clinic

E-Posters | June 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: A330-A331

10.1136/gutjnl-2026-bsg.517 Get It

Blood Urea Nitrogen‐to‐Creatinine Ratio to Differentiate Upper From Lower Gastrointestinal Bleeding: A Systematic Review and Meta‐Analysis
Koo, Thai Hau , Murlidhar, Murlidhar, Lamichhane, Ramesh , Rampengan, Derren David Christian Homenta, Danpanichkul, Pojsakorn , Wong, Richard C. K., Koo, Thai Hau , Danpanichkul, Pojsakorn , Simadibrata, Daniel Martin , Rampengan, Derren David Christian Homenta , Wong, Richard C.K.

Mayo Clinic

Journal of Gastroenterology and Hepatology | January 20, 2026 | Volume: 41 | Issue: 2 | Pages: 477-487

10.1111/jgh.70224 | PMID 41555211 Get It

ABSTRACT Background and Aim Determining the location of gastrointestinal (GI) bleeding is critical for guiding diagnostic and therapeutic strategies but often results in patients receiving pan‐endoscopy with upper endoscopy, colonoscopy, and small bowel capsule endoscopy, which can be unnecessary, costly, and waste limited healthcare resources. The blood urea nitrogen‐to‐creatinine ratio (BUN/Cr) may help discriminate between upper GI bleeding (UGIB) and lower GI bleeding (LGIB). This study aims to assess the diagnostic performance of the BUN/Cr in distinguishing UGIB from LGIB. Methods A literature search was conducted in MEDLINE, EMBASE, and Cochrane Library to identify diagnostic test accuracy studies published from inception through January 31, 2025, which evaluated BUN/Cr in patients with UGIB versus LGIB. A linear mixed‐effects model meta‐analysis was conducted using the “diagmeta” package. The pooled sensitivity, specificity, diagnostic odds ratio, and area under the summary receiver operating characteristic curve (AUC) were estimated, and optimal threshold was determined using the Youden index. Results Seventeen studies were included in this meta‐analysis. The pooled mean difference in BUN/Cr between UGIB and LGIB patients was 11.44 (95% confidence interval [95% CI] 8.35–14.52). At a threshold of > 30, pooled sensitivity was 38.8% (95% CI 28.1%–50.8%) and specificity was 89.3% (95% CI 81.0%–94.2%). At the optimal cut‐off of 22, sensitivity was 66.2% (95% CI 57.8%–73.7%), specificity was 71.0% (95% CI 58.5%–81.0%), and AUC was 0.740 (95% CI 0.683–0.794). Conclusion BUN/Cr demonstrates moderate diagnostic accuracy for distinguishing UGIB from LGIB, particularly at a threshold of ≥ 22. This readily accessible and inexpensive blood test may assist in early clinical triage and assessment of the location of GI bleeding, particularly in those patients where the clinical presentation is obscure.
Diagnostic Accuracy Performance of Fluorescence In Situ Hybridization (FISH) for Biliary Strictures: A Systematic Review and Meta-Analysis
Aggarwal, Manik , Simadibrata, Daniel M., Kipp, Benjamin R. , Fritcher, Emily G. Barr , Schneider, Amber, Cooley, Matthew A. , Gores, Gregory J. , Eaton, John E. , Roberts, Lewis R. , Gores, Gregory J. , Barr Fritcher, Emily G , Eaton, John, Roberts, Lewis R , Prokop, Larry J. , Chandrasekhara, Vinay

Mayo Clinic

Journal of Clinical Medicine | October 28, 2024 | Volume: 13 | Issue: 21 | Pages: 6457

10.3390/jcm13216457 | PMID 39518600 Get It

Background and Aims: This systematic review and meta-analysis aims to compare the performance of UroVysion® FISH based on the different definitions of a positive result used in published literature with the goal of determining the optimal FISH definition for detecting pancreaticobiliary malignancy. Methods: A systematic literature search identified studies from database inception to Sept 2024 that evaluated the diagnostic performance of FISH in determining malignancy among patients with biliary strictures. All thresholds for positive FISH, as defined by the individual study, were included in this review. Subgroup analysis was performed based on the definitions of positive FISH as follows: (1) polysomy only; (2) polysomy, tetrasomy, or trisomy; and (3) polysomy or 9p deletion. Results: Eighteen studies comprising 2516 FISH specimens were analyzed, including 1133 (45.0%) with malignancy. Using a threshold for positivity as defined in individual studies, the overall sensitivity of FISH was 57.6% (95% confidence interval [CI], 49.4–65.4%), and the overall specificity was 87.8% (95% CI, 79.2–93.2%). Subgroup analysis showed that polysomy as the threshold for positive FISH yielded a sensitivity of 49.4% (95% CI, 43.2–55.5%), with an increased specificity of 96.2% (95% CI, 92.7–98.1%), while polysomy + tetrasomy/trisomy as positive FISH resulted in an increased sensitivity of 64.3% (95% CI 55.4–72.2%) but a decreased specificity of 78.9% (95% CI 64.4–88.5%). The addition of 9p deletion to polysomy as the criteria for a positive test resulted in a non-significant increase in sensitivity (54.7% (95% CI 42.4–66.5%) while maintaining specificity (95.1% (95% CI 84.0–98.6%). Conclusions: Based on these findings, polysomy only or polysomy/9p deletion should be considered as the criterion for defining a positive FISH test to improve diagnostic sensitivity while maintaining high specificity.
S1648 Safety and Efficacy of Endoscopic Ultrasound-Guided Pelvic Abscess Drainage: An Updated Systematic Review and Meta-Analysis
Lamichhane, Ramesh , Cohen, Ethan M. , Adekolu, Ayowumi A. , Agrawal, Rohit , Thakkar, Shyam, Pathak, Bishnu Deep , Simadibrata, Daniel Martin

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S1200-S1201

10.14309/01.ajg.0001035960.04129.e3 Get It

S1596 Comparison of Nutritional Parameters, Efficacy, and Safety of Endoscopic Gastrojejunostomy versus Duodenal Self-Expandable Metal Stent for the Management of Malignant Gastric Outlet Obstruction
Law, Ryan , Bofill-García, Aliana, Bauss, Jacob M. , AbiMansour, Jad P. , Siranart, Noppachai , Simadibrata, Daniel Martin , Storm, Andrew C. , Vargas, Eric J. , Dayyeh, Barham K. Abu , Chandrasekhara, Vinay

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S1158-S1158

10.14309/01.ajg.0001035752.19015.60 Get It

Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?
Simadibrata, Daniel Martin , Lesmana, Elvira , Lee, Yeong Yeh , Lee, Yeong Yeh

Mayo Clinic

Expert Opinion on Investigational Drugs | August 17, 2024 | Volume: 33 | Issue: 10 | Pages: 1009-1018

10.1080/13543784.2024.2393868 | PMID 39152730 Get It

Clostridioides difficile Infection in the Elderly: Trend Analysis from 2000 to 2019
Danpanichkul, Pojsakorn , Uawithya, Ekdanai , Kongarin, Siwanart , Polpichai, Natchaya , Suenghataiphorn, Thanathip , Wattanachayakul, Phuuwadith , Pang, Yanfang , Sukphutanan, Banthoon , Kaewdech, Apichat , Panpradist, Nuttada , Chaiyakunapruk, Nathorn , Pupaibool, Jakrapun , Wijarnpreecha, Karn , Uawithya, Ekdanai , Polpichai, Natchaya , Suenghataiphorn, Thanathip , Kaewdech, Apichat , Panpradist, Nuttada , Chaiyakunapruk, Nathorn , Pupaibool, Jakrapun , Wijarnpreecha, Karn , Danpanichkul, Pojsakorn , Duangsonk, Kwanjit , Simadibrata, Daniel Martin , Pang, Yanfang

Mayo Clinic

Journal of Clinical Medicine | June 26, 2024 | Volume: 13 | Issue: 13 | Pages: 3740

10.3390/jcm13133740 | PMID 38999306 Get It

Background/Objective: Clostridioides difficile infection (CDI) is a common healthcare-associated ailment, presenting major health and economic challenges, especially for the elderly. Despite its prevalence, comprehensive data about CDI’s impact on the elderly are limited. Methods: This study used the Global Burden of Disease Study 2019 data to analyze CDI trends from 2000 to 2019, considering factors like sex, region, and sociodemographic index (SDI). Results: This study revealed that CDI caused approximately 18,181 deaths and 252,709 disability-adjusted life years (DALYs) among the elderly worldwide. The Americas showed the highest CDI burden, while the Eastern Mediterranean saw the steepest rate increase from 2000 to 2019. Regions with a high SDI also displayed substantial CDI impact. Conclusions: The escalating burden of CDI in the elderly, especially in high-SDI areas and the Americas, emphasizes an urgent need for targeted public health strategies.
Global epidemiology of early‐onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019
Danpanichkul, Pojsakorn , Auttapracha, Thanida , Kongarin, Siwanart , Jaruvattanadilok, Supitchaya , Saowapa, Sakditad , Suparan, Kanokphong , Liangpunsakul, Suthat , Wallace, Michael B. , Lui, Rashid , Wijarnpreecha, Karn , Wallace, Michael B , Danpanichkul, Pojsakorn , Ponvilawan, Ben , Simadibrata, Daniel Martin , Duangsonk, Kwanjit , Wijarnpreecha, Karn

Mayo Clinic

Journal of Gastroenterology and Hepatology | May 22, 2024 | Volume: 39 | Issue: 9 | Pages: 1856-1868

10.1111/jgh.16620 | PMID 38772743 Get It

AbstractBackground and AimIn recent years, there has been a growing incidence of gastrointestinal cancer in young individuals. Despite its significant morbidity and mortality, research on upper gastrointestinal (UGI) cancer in young populations has been relatively limited. Therefore, studies on the epidemiological changes of this cancer are needed.MethodsUsing data from the Global Burden of Disease Study 2019, we examined the incidence, death, and disability‐adjusted life years (DALYs) from UGI cancers in the young, namely, early‐onset esophageal cancer (EOEC) and early‐onset gastric cancer (EOGC). These results were stratified by sex, geographical region, country, and sociodemographic index.ResultsThere was a total of 185 140 cases, 120 289 deaths, and 5.70 million DALYs attributable to early‐onset UGI cancers globally. From 2010 to 2019, the global incidence, death, and DALYs rates of early‐onset UGI cancers decreased. In contrast, the incidence rates increased in both EOEC (+1.15%) and EOGC (+0.21%) in the Eastern Mediterranean region.ConclusionsOver the past decade, the burden of UGI cancer in the young has decreased. However, it has increased in the Eastern Mediterranean region. Further research to elucidate the attributable risk factors in this population is warranted.
Meta-analysis of diagnostic performance of fluorescence in situ hybridization (FISH) for biliary strictures
Aggarwal, Manik , Simadibrata, Daniel M., Petersen, Bret T. , Martin, John A. , Barr-Fritcher, E., Schneider, A., Kipp, Benjamin R. , Chandrasekhara, V., Petersen, Bret T. , Schneider, A., Roberts, Lewis R. , Gores, Gregory J.

Mayo Clinic

Endoscopy | April 23, 2024 | Volume: 56 | Issue: S 02 | Pages: S138-S138

10.1055/s-0044-1782991 Get It